Erye Biology: Yidarui, Yikaire, and Wang Tianyi plan to reduce their holdings of the company's shares by no more than 3.25% respectively.

On March 19, Jinshi Data reported that Eryi Biological announced that its controlling shareholder and actual controller’s concerted action parties, Yidarui and Yikairei, as well as the shareholder holding more than 5% of the shares, Wang Tianyi, plan to reduce their holdings of the company’s shares through centralized bidding or block trading from April 11, 2025, to July 10, 2025. Yidarui plans to reduce its holdings by no more than 411,200 shares, accounting for 0.1026% of the company’s total share capital; Yikairei plans to reduce its holdings by no more than 575,700 shares, accounting for 0.1436% of the company’s total share capital; Wang Tianyi plans to reduce his holdings by no more than 12,026,000 shares, accounting for 3.0000% of the company’s total share capital. The reason for the reduction is due to the need for personal funds.